ME/CFS Evidence Browser — Classified Studies on Myalgic Encephalomyelitis

81–100 of 270 studies

Multimodal MRI of myalgic encephalomyelitis/chronic fatigue syndrome: A cross-sectional neuroimaging study toward its neuropathophysiology and diagnosis.

Shan, Zack Y, Mohamed, Abdalla Z, Andersen, Thu et al.·Frontiers in neurology·2022

This study used advanced brain imaging to investigate whether ME/CFS is caused by a problem with how the brain's blood vessels respond to neural activity. Researchers scanned the brains of 288 people—including those with ME/CFS, chronic fatigue, fibromyalgia, and healthy controls—while they performed tasks and held their breath, measuring blood flow and brain chemicals. The goal was to find distinctive brain patterns that could objectively diagnose ME/CFS and understand what goes wrong in this disease.

Biomarkers

E2 ModerateCohortPEM unclearCase-Control

Revisiting IgG Antibody Reactivity to Epstein-Barr Virus in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Its Potential Application to Disease Diagnosis.

Sepúlveda, Nuno, Malato, João, Sotzny, Franziska et al.·Frontiers in medicine·2022

This study looked at antibody responses to Epstein-Barr virus (EBV), a common virus linked to ME/CFS onset in some patients. Researchers analyzed blood samples from 92 ME/CFS patients and 50 healthy people, testing reactions to over 3,000 EBV proteins. They found that in patients whose ME/CFS started after a suspected EBV infection, two specific viral proteins triggered stronger antibody responses than in healthy controls. These antibody patterns could correctly identify about 83% of infected patients and 72% of healthy people, suggesting they might become useful diagnostic markers.

BiomarkersImmune System

E2 ModerateCohortPEM unclearCross-Sectional

Biomarkers in the diagnostic algorithm of myalgic encephalomyelitis/chronic fatigue syndrome.

Gravelsina, Sabine, Vilmane, Anda, Svirskis, Simons et al.·Frontiers in immunology·2022

This study looked for biological markers (measurable signs in the blood) that could help doctors diagnose ME/CFS more easily. Researchers tested 134 ME/CFS patients and 33 healthy people for a virus called HHV-6 and specific antibodies that attack nerve receptors. They found that ME/CFS patients had higher levels of certain antibodies compared to healthy controls, and patients with more virus in their blood tended to have more severe symptoms.

BiomarkersImmune System

E2 ModerateCohortPEM unclearCross-Sectional

Comparative Analysis of Extracellular Vesicles in Patients with Severe and Mild Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

Bonilla, Hector, Hampton, Dylan, Marques de Menezes, Erika G et al.·Frontiers in immunology·2022

Researchers looked for tiny particles called extracellular vesicles in the blood of people with ME/CFS to see if they could help diagnose or understand the disease. They found that people with severe ME/CFS had higher levels of certain vesicles that come from B cells (immune cells) and platelets (blood clotting cells) compared to healthy people. While these differences were promising, they weren't strong enough to confirm they're reliable markers yet.

BiomarkersImmune System

E2 ModerateCohortPEM unclearCross-Sectional

Autoimmune gene expression profiling of fingerstick whole blood in Chronic Fatigue Syndrome.

Wang, Zheng, Waldman, Michelle F, Basavanhally, Tara J et al.·Journal of translational medicine·2022

Researchers tested blood samples from 166 ME/CFS patients and 83 healthy people to look for immune system clues that might explain the disease. They found that six specific genes related to immune function were more active in patients with severe, bedridden ME/CFS compared to those with milder disease. The study suggests these genes could potentially be used as biomarkers to identify how severe someone's ME/CFS is and might point toward new treatments.

BiomarkersImmune System

E2 ModerateCohortPEM not requiredObservational

HERV-W ENV antigenemia and correlation of increased anti-SARS-CoV-2 immunoglobulin levels with post-COVID-19 symptoms.

Giménez-Orenga, Karen, Pierquin, Justine, Brunel, Joanna et al.·Frontiers in immunology·2022

This study found that a dormant virus-like element called HERV-W, which exists naturally in our DNA, may reactivate and remain active long after COVID-19 infection has cleared in people with long COVID. The researchers also discovered that people with higher levels of certain immune proteins (antibodies) against SARS-CoV-2, especially IgE antibodies, tended to have worse physical function. These findings suggest that HERV-W activation and lingering antibody responses might help explain why some people develop long-lasting COVID symptoms.

BiomarkersImmune System

E2 ModerateCohortPEM unclearCross-Sectional

No difference in serum levels of B-cell activating receptor and antibodies against cytolethal distending toxin B and flagellin in post-infectious irritable bowel syndrome and chronic fatigue syndrome after Giardia infection.

Hanevik, Kurt, Saghaug, Christina, Aaland, Maren et al.·JGH open : an open access journal of gastroenterology and hepatology·2022

This study looked for three potential biological markers (BAFF, anti-CdtB, and anti-flagellin antibodies) in the blood of people who developed ME/CFS and/or IBS after a Giardia infection. Researchers compared these markers in patients to healthy controls but found no significant differences between the groups. The findings suggest these three markers are not useful for diagnosing ME/CFS or IBS.

BiomarkersImmune System

E2 ModerateCohortPEM not requiredCross-Sectional

Post-COVID-19 Syndrome: Retinal Microcirculation as a Potential Marker for Chronic Fatigue.

Schlick, Sarah, Lucio, Marianna, Wallukat, Gerd et al.·International journal of molecular sciences·2022

Researchers studied whether tiny blood vessels in the eye could be a measurable sign of fatigue in people with long COVID. Using a special imaging technique to look at blood vessels in the retina (back of the eye), they found that people with long COVID—especially women—had reduced blood flow in these tiny vessels compared to healthy people. Those with long COVID who reported severe fatigue had even lower blood vessel density than those with milder fatigue, suggesting the eye scan might objectively confirm what patients report feeling.

Biomarkers

E2 ModerateCohortPEM unclearCross-Sectional

Analysis of Gender Differences in HRV of Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Using Mobile-Health Technology.

Capdevila, Lluis, Castro-Marrero, Jesús, Alegre, José et al.·Sensors (Basel, Switzerland)·2021

Researchers used a smartphone app connected to a heart monitor to measure heart rate variability (how much the time between heartbeats varies) in ME/CFS patients and healthy people. They found that women with ME/CFS showed different heart patterns than healthy women, but men with ME/CFS did not show the same clear difference. This suggests that ME/CFS may affect the heart's nervous system control differently in men versus women.

Biomarkers

E2 ModerateCohortPEM unclearCross-Sectional

Are Circulating Fibroblast Growth Factor 21 and N-Terminal Prohormone of Brain Natriuretic Peptide Promising Novel Biomarkers in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome?

Domingo, Joan Carles, Cordobilla, Begoña, Ferrer, Roser et al.·Antioxidants & redox signaling·2021

This study looked for new blood markers that could help identify ME/CFS by measuring two proteins called FGF21 and NT-proBNP in patients and healthy people. The researchers found that ME/CFS patients had significantly higher levels of both proteins and showed signs of increased inflammation and oxidative stress (cellular damage). These findings suggest these proteins might be useful tools for diagnosing ME/CFS or developing new treatments.

BiomarkersImmune System

E2 ModerateCohortPEM unclearObservational

Sex-specific plasma lipid profiles of ME/CFS patients and their association with pain, fatigue, and cognitive symptoms.

Nkiliza, Aurore, Parks, Megan, Cseresznye, Adam et al.·Journal of translational medicine·2021

This study analyzed fatty substances in the blood of ME/CFS patients and healthy controls to see if they differ in ways that might explain symptoms. Researchers found that men and women with ME/CFS had different patterns of these blood fats compared to healthy people. Importantly, certain blood fats were connected to the severity of fatigue, headaches, and thinking difficulties, suggesting that problems with how the body processes fats may play a role in ME/CFS symptoms.

BiomarkersEnergy MetabolismImmune System

E2 ModerateCohortPEM unclearCross-Sectional

Sex-Based Differences in Plasma Autoantibodies to Central Nervous System Proteins in Gulf War Veterans versus Healthy and Symptomatic Controls.

Abou-Donia, Mohamed B, Krengel, Maxine H, Lapadula, Elizabeth S et al.·Brain sciences·2021

Researchers found that Gulf War veterans with Gulf War illness have abnormal immune proteins in their blood that attack brain cells, and these patterns differ between men and women. The study also found that these same immune markers can help distinguish Gulf War illness from other similar conditions like ME/CFS and IBS. This discovery is important because it offers a possible objective blood test that doctors could use to identify and diagnose these difficult-to-recognize illnesses.

BiomarkersImmune System

E2 ModerateCohortPEM unclearCross-Sectional

Recursive ensemble feature selection provides a robust mRNA expression signature for myalgic encephalomyelitis/chronic fatigue syndrome.

Metselaar, Paula I, Mendoza-Maldonado, Lucero, Li Yim, Andrew Yung Fong et al.·Scientific reports·2021

Researchers found a set of 23 genes in blood cells that could reliably identify people with ME/CFS. By looking at both gene activity and chemical markers on genes, they developed a test that correctly identified ME/CFS patients about 92-97% of the time. This is important because there's currently no reliable blood test to diagnose ME/CFS.

BiomarkersImmune System

E2 ModerateCohortPEM not requiredCross-Sectional

The maintained attention assessment in patients affected by Myalgic encephalomyelitis/chronic fatigue syndrome: a reliable biomarker?

Murga, Iñigo, Aranburu, Larraitz, Gargiulo, Pascual A et al.·Journal of translational medicine·2021

This study looked at attention problems in ME/CFS patients by giving them a simple attention test (the Toulouse-Piéron test) and comparing their results to healthy people. Most ME/CFS patients had normal overall thinking skills, but 70% showed very low attention scores and complained of mental fatigue. Women with ME/CFS reported feeling more effort during the test than men did, even though their attention scores were similar.

Biomarkers

E2 ModerateCohortPEM unclearObservational

Evaluation of Immune Dysregulation in an Austrian Patient Cohort Suffering from Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

Lutz, Lena, Rohrhofer, Johanna, Zehetmayer, Sonja et al.·Biomolecules·2021

This study looked at blood test results from 262 ME/CFS patients to understand problems with their immune systems. Researchers found that nearly two-thirds of patients had low levels of certain immune proteins or cells, while about one-quarter showed signs of inflammation. These findings suggest that immune system dysfunction is a common feature of ME/CFS and could potentially be used to help diagnose or treat the condition.

BiomarkersImmune System

E2 ModerateCohortPEM unclearCross-Sectional

Exercise modifies glutamate and other metabolic biomarkers in cerebrospinal fluid from Gulf War Illness and Myalgic encephalomyelitis / Chronic Fatigue Syndrome.

Baraniuk, James N, Kern, Grant, Narayan, Vaishnavi et al.·PloS one·2021

Researchers studied the fluid around the brain and spinal cord in people with ME/CFS and Gulf War Illness to see how exercise affects certain chemicals in the body. They found that glutamate (a brain chemical) levels changed differently depending on whether someone had exercised and how their body responded, and that some fat-related molecules were different between the two conditions. This suggests that ME/CFS and Gulf War Illness may involve different problems with how the body uses energy and processes fats.

NeuroinflammationBiomarkersPost-Exertional Malaise

E2 ModerateCohortPEM not requiredCross-Sectional

Potential of Activin B as a Clinical Biomarker in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).

Gravelsina, Sabine, Nora-Krukle, Zaiga, Vilmane, Anda et al.·Biomolecules·2021

Researchers tested whether a protein called activin B could be used as a simple blood test to diagnose ME/CFS. They compared activin B levels in 134 people with ME/CFS and 54 healthy people, but found no meaningful difference between the two groups. Based on these results, activin B does not appear to be a useful diagnostic tool for ME/CFS.

Biomarkers

E2 ModerateCohortPEM unclearCross-Sectional

Plasma proteomic profiling suggests an association between antigen driven clonal B cell expansion and ME/CFS.

Milivojevic, Milica, Che, Xiaoyu, Bateman, Lucinda et al.·PloS one·2020

Researchers studied blood proteins in ME/CFS patients and healthy controls to look for disease markers. They found that certain immune-related proteins, particularly immunoglobulin proteins (which are part of the immune system), were abnormal in ME/CFS patients and could help identify who has the disease. The results suggest ME/CFS involves an overactive or dysregulated immune response.

BiomarkersImmune System

E2 ModerateCohortPEM unclearCross-Sectional

Identification of actin network proteins, talin-1 and filamin-A, in circulating extracellular vesicles as blood biomarkers for human myalgic encephalomyelitis/chronic fatigue syndrome.

Eguchi, Akiko, Fukuda, Sanae, Kuratsune, Hirohiko et al.·Brain, behavior, and immunity·2020

This study found that people with ME/CFS have higher levels of tiny particles called extracellular vesicles in their blood, which contain specific proteins (talin-1 and filamin-A) that appear to be unique markers of the disease. By measuring these particles and proteins in a simple blood test, researchers were able to correctly identify ME/CFS patients about 90-94% of the time, suggesting this could become a useful diagnostic tool.

BiomarkersImmune System

E2 ModerateCohortPEM unclearCross-Sectional

Properties of measurements obtained during cardiopulmonary exercise testing in individuals with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

Davenport, Todd E, Stevens, Staci R, Stevens, Jared et al.·Work (Reading, Mass.)·2020

Researchers tested whether a standard exercise test (cardiopulmonary exercise test, or CPET) could reliably measure how ME/CFS affects the body's ability to exercise. They had 51 women with ME/CFS and 10 healthy women do the same exercise test twice, 24 hours apart. The results showed that the measurements were consistent and clearly different between the two groups, suggesting that CPET could be a useful tool for assessing ME/CFS.

Biomarkers

← Previous Next 20 studies →

Or browse by topic

PEM Immune Neuro Metabolic Biomarkers Severe ME Long COVID Cognitive

Evidence Atlas

Evidence browser

Multimodal MRI of myalgic encephalomyelitis/chronic fatigue syndrome: A cross-sectional neuroimaging study toward its neuropathophysiology and diagnosis.

Revisiting IgG Antibody Reactivity to Epstein-Barr Virus in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Its Potential Application to Disease Diagnosis.

Biomarkers in the diagnostic algorithm of myalgic encephalomyelitis/chronic fatigue syndrome.

Comparative Analysis of Extracellular Vesicles in Patients with Severe and Mild Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

Autoimmune gene expression profiling of fingerstick whole blood in Chronic Fatigue Syndrome.

HERV-W ENV antigenemia and correlation of increased anti-SARS-CoV-2 immunoglobulin levels with post-COVID-19 symptoms.

No difference in serum levels of B-cell activating receptor and antibodies against cytolethal distending toxin B and flagellin in post-infectious irritable bowel syndrome and chronic fatigue syndrome after Giardia infection.

Post-COVID-19 Syndrome: Retinal Microcirculation as a Potential Marker for Chronic Fatigue.

Analysis of Gender Differences in HRV of Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Using Mobile-Health Technology.

Are Circulating Fibroblast Growth Factor 21 and N-Terminal Prohormone of Brain Natriuretic Peptide Promising Novel Biomarkers in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome?

Sex-specific plasma lipid profiles of ME/CFS patients and their association with pain, fatigue, and cognitive symptoms.

Sex-Based Differences in Plasma Autoantibodies to Central Nervous System Proteins in Gulf War Veterans versus Healthy and Symptomatic Controls.

Recursive ensemble feature selection provides a robust mRNA expression signature for myalgic encephalomyelitis/chronic fatigue syndrome.

The maintained attention assessment in patients affected by Myalgic encephalomyelitis/chronic fatigue syndrome: a reliable biomarker?

Evaluation of Immune Dysregulation in an Austrian Patient Cohort Suffering from Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

Exercise modifies glutamate and other metabolic biomarkers in cerebrospinal fluid from Gulf War Illness and Myalgic encephalomyelitis / Chronic Fatigue Syndrome.

Potential of Activin B as a Clinical Biomarker in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).

Plasma proteomic profiling suggests an association between antigen driven clonal B cell expansion and ME/CFS.

Identification of actin network proteins, talin-1 and filamin-A, in circulating extracellular vesicles as blood biomarkers for human myalgic encephalomyelitis/chronic fatigue syndrome.

Properties of measurements obtained during cardiopulmonary exercise testing in individuals with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

Curated Collections

Neuroinflammation Evidence

Metabolism & Mitochondria

Biomarkers

PEM-Specific Research